Análisis de la política de fijación de precios de medicamentos y su impacto en los márgenes de rentabilidad de las empresas farmacéuticas domiciliadas en Quito bajo el control de la superintendencia de compañías valores y seguros, periodo 2016-2019.

Abstract

This research work analyzes the impact that the implementation of the drug pricing policy has had and its result on the profitability margins of pharmaceutical companies under the control of the Superintendency of Securities and Insurance Companies, through a descriptive and exploratory investigation. Information and data were collected from primary sources through surveys and from analysis of financial and economic data provided by public and private entities that are related to the sector under analysis. In addition to secondary sources, such as sectorial studies generated by academia and trade union entities, which has allowed to identify the important contribution that this control mechanism has made to the development of the pharmaceutical sector both at the national level and the one domiciled in the city of Quito in the period 2016-2019, which results reveal an increase in the participation of this industry in the national market, its sales and a moderate maintenance of financial indicators, accompanied by a commitment to productive and technological investment to improve competitiveness with international markets and satisfying the needs of the local private and institutional market, it shows a positive contribution of this control mechanism in the development and expectations of the sector.